{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T10:47:23Z","timestamp":1761821243975},"reference-count":22,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2010,7,1]],"date-time":"2010-07-01T00:00:00Z","timestamp":1277942400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2010,7]]},"DOI":"10.1016\/j.leukres.2010.02.036","type":"journal-article","created":{"date-parts":[[2010,4,3]],"date-time":"2010-04-03T08:33:34Z","timestamp":1270283614000},"page":"e154-e156","source":"Crossref","is-referenced-by-count":15,"title":["Guillain\u2013Barr\u00e9 syndrome after use of alemtuzumab (Campath) in a patient with T-cell prolymphocytic leukemia: A case report and review of the literature"],"prefix":"10.1016","volume":"34","author":[{"given":"Kamal K.S.","family":"Abbi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Syed M.","family":"Rizvi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey","family":"Sivik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Subramanian","family":"Thyagarajan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Loughran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph J.","family":"Drabick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.leukres.2010.02.036_bib1","first-page":"333","article-title":"Schipperus Experience with alemtuzumab in treatment of chronic lymphocytic leukaemia in The Netherlands","volume":"65","author":"Laros-van Gorkom","year":"2007","journal-title":"Neth J Med"},{"key":"10.1016\/j.leukres.2010.02.036_bib2","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1111\/j.1600-6143.2006.01258.x","article-title":"Autoimmune thyroid Disease after renal transplantation using depletional induction with alemtuzumab","volume":"6","author":"Kirk","year":"2006","journal-title":"Am J Transplant"},{"key":"10.1016\/j.leukres.2010.02.036_bib3","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1182\/blood-2006-07-035766","article-title":"Development of a secondary autoimmune disorder after hematopoietic stem cell transplantation for autoimmune diseases: role of conditioning regimen used","volume":"109","author":"Loh","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2010.02.036_bib4","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.3324\/haematol.10733","article-title":"Red cell aplasia and autoimmune hemolytic anemia following immunosuppression with alemtuzumab, mycophenolate, and daclizumab in pancreas transplant recipients","volume":"92","author":"Elimelakh","year":"2007","journal-title":"Haematologica"},{"key":"10.1016\/j.leukres.2010.02.036_bib5","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0145-2126(97)00158-6","article-title":"Levels of expression of CD52 in normal and leukemic Band T cells: correlation with in vivo therapeutic responses to Campath-1H","volume":"22","author":"Ginaldi","year":"1998","journal-title":"Leuk Res"},{"key":"10.1016\/j.leukres.2010.02.036_bib6","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/j.1399-0039.1990.tb01767.x","article-title":"The CAMPATH-1 antigen (CDw52)","volume":"35","author":"Hale","year":"1990","journal-title":"Tissue Antigens"},{"issue":"June (6)","key":"10.1016\/j.leukres.2010.02.036_bib7","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/j.1600-0609.2008.01069.x","article-title":"E Prolymphocytic leukemia of B and T cell subtype\u2014a state of the art paper","volume":"80","author":"Dungarwalla m","year":"2008","journal-title":"Eur J Hematol"},{"key":"10.1016\/j.leukres.2010.02.036_bib8","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1046\/j.1365-2567.1996.d01-650.x","article-title":"Repopulation of blood lymphocyte sub-populations in rheumatoid arthritis patients treated with the depleting humanized monoclonal antibody, CAMPATH-1H","volume":"88","author":"Brett","year":"1996","journal-title":"Immunology"},{"key":"10.1016\/j.leukres.2010.02.036_bib9","doi-asserted-by":"crossref","first-page":"3121","DOI":"10.1182\/blood-2002-03-0701","article-title":"Nonmyeloablative transplantation with or without alemtuzumab: comparison between 2 prospective studies in patients with lymphoproliferative disorders","volume":"100","author":"P\u00e9rez-Sim\u00f3n","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2010.02.036_bib10","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/sj.bmt.1704322","article-title":"Alemtuzumab can successfully treat steroid-refractory acute graft-versus-host disease (aGVHD)","volume":"33","author":"Carella","year":"2004","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.leukres.2010.02.036_bib11","first-page":"1248","article-title":"Cytomegalovirus reactivation during alemtuzumab therapy for chronic lymphocytic leukemia: incidence and treatment with oral ganciclovir","volume":"89","author":"Laurenti","year":"2004","journal-title":"Haematologica"},{"key":"10.1016\/j.leukres.2010.02.036_bib12","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1182\/blood-2002-04-1093","article-title":"Differential CD52 expression by distinct myeloid dendritic cell subsets: implications for alemtuzumab activity at the level of antigen presentation in allogeneic graft\u2013host interactions in transplantation","volume":"101","author":"Ratzinger","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2010.02.036_bib13","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1182\/blood.V100.5.1715.h81702001715_1715_1720","article-title":"Peripheral blood but not tissue dendritic cells express CD52 and are depleted by treatment with alemtuzumab","volume":"100","author":"Buggins","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2010.02.036_bib14","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.imlet.2004.04.015","article-title":"Regulatory T cells and tolerogenic dendritic cells: from basicbiology to clinical applications","volume":"94","author":"Rutella","year":"2004","journal-title":"Immunol Lett"},{"key":"10.1016\/j.leukres.2010.02.036_bib15","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1532\/IJH97.04165","article-title":"Dendritic cells: sentinels of immunity and tolerance","volume":"81","author":"Kubach","year":"2005","journal-title":"Int J Hematol"},{"key":"10.1016\/j.leukres.2010.02.036_bib16","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.it.2005.08.008","article-title":"NK cells: elusive players in autoimmunity","volume":"26","author":"Johansson","year":"2005","journal-title":"Trends Immunol"},{"key":"10.1016\/j.leukres.2010.02.036_bib17","doi-asserted-by":"crossref","first-page":"3332","DOI":"10.1002\/eji.200535075","article-title":"Lymphocyte homeostasis following therapeutic lymphocyte depletion in multiple sclerosis","volume":"35","author":"Cox","year":"2005","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.leukres.2010.02.036_bib18","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1053\/j.ajkd.2006.01.009","article-title":"Acquired hemophilia in association with ANCA-associated vasculitis: response to rituximab","volume":"47","author":"Clatworthy","year":"2006","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.leukres.2010.02.036_bib19","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1084\/jem.20062567","article-title":"BAFF and MyD88 signals promote a lupuslike disease independent of T cells","volume":"204","author":"Groom","year":"2007","journal-title":"J Exp Med"},{"key":"10.1016\/j.leukres.2010.02.036_bib20","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1007\/s12094-006-0126-5","article-title":"Guillain\u2013Barr\u00e9 syndrome in a patient with diffuse large B-cell lymphoma, and rituximab maintenance therapy. An association beyond anecdotal evidence?","volume":"8","author":"Carmona","year":"2006","journal-title":"Clin Transl Oncol"},{"issue":"November","key":"10.1016\/j.leukres.2010.02.036_bib21","article-title":"Pascual\u2013Guillain\u2013Barr\u00e9 Julio syndrome after rituximab in a patient with idiopathic thombocytopenic purpura: a causal association?","author":"Jaso","year":"2009","journal-title":"J Neurol"},{"issue":"Supplement","key":"10.1016\/j.leukres.2010.02.036_bib22","first-page":"1","article-title":"Guillain\u2013Barr\u00e9 syndrome in a chronic lymphocytic leukaemia (CLL) patient after subcutaneous alemtuzumab and high dose of prednisone therapy","volume":"14","author":"Castelli","year":"2009","journal-title":"J Peripher Nerv Syst"}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212610001190?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212610001190?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,6,3]],"date-time":"2020-06-03T13:26:21Z","timestamp":1591190781000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212610001190"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,7]]},"references-count":22,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2010,7]]}},"alternative-id":["S0145212610001190"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2010.02.036","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2010,7]]}}}